StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

GMED — Globus Medical, Inc.

EXPENSIVE (MOS -27.4%) · Quality 64/100

Price
74.08
Intrinsic value
58.17
Margin of safety
-27.4%
Implied growth (reverse DCF)
+3.3%
model assumes +0.0%
Value Score
23.5
Quality
64
Psychology
16.1
Discovery
18.4
price/volume attention only
Moat score
22
erosion: watch

Value Score: bottom 23% of Russell 3000 · Quality: bottom 46%

Open the interactive Deep Dive for GMED →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/GMED - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is GMED undervalued?

As of 2026-09-19, GMED trades at 74.08 against a computed intrinsic value of 58.17 (-27.4% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Globus Medical, Inc.'s Value Score?

Globus Medical, Inc.'s Value Score is 23.5 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.